UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 761

Sortiert nach

Complementary stimulation of hepatobiliary transport and detoxification systems by rifampicin and ursodeoxycholic acid in humans

Gastroenterology (New York, N.Y. 1943), 2005-08, Vol.129 (2), p.476-485

2005

Volltextzugriff (PDF)

Curcumin improves sclerosing cholangitis in Mdr2−/− mice by inhibition of cholangiocyte inflammatory response and portal myofibroblast proliferation

Gut, 2010-04, Vol.59 (4), p.521-530

2010

Volltextzugriff (PDF)

50 PREGNANCY RESOLVES LIVER FIBROSIS AND IMPROVES SCLEROSING CHOLANGITIS IN MDR2 (ABCB4) −/− MICE VIA DIRECT ANTI-INFLAMMATORY EFFECTS OF SEX HORMONES

Journal of hepatology, 2010, Vol.52, p.S24-S24

2010

Volltextzugriff (PDF)

Fouling-Release Performance of Silicone Oil-Modified Siloxane-Polyurethane Coatings

ACS applied materials & interfaces, 2016-10, Vol.8 (42), p.29025-29036

2016

Volltextzugriff (PDF)

Biobased, Nonisocyanate, 2K Polyurethane Coatings Produced from Polycarbamate and Dialdehyde Cross-linking

ACS sustainable chemistry & engineering, 2019-12, Vol.7 (24), p.19621-19630

2019

Volltextzugriff (PDF)

1307 HIGH LEVELS OF URSODEOXYCHOLIC ACID ACT AS FXR ANTAGONIST AND DEPLETE LIVER CHOLESTEROL DUE TO INCREASED BILE ACID SYNTHESIS IN MORBIDLY OBESE PATIENTS

Journal of hepatology, 2012-04, Vol.56, p.S515-S515

2012

Volltextzugriff (PDF)

Exploration of Bio-Based Functionalized Sucrose Ester Resins for Additive Manufacturing via Stereolithography

ACS applied polymer materials, 2020-07, Vol.2 (7), p.2910-2918

2020

Volltextzugriff (PDF)

Instrument Referral Criteria for PlusoptiX, SPOT and 2WIN Targeting 2021 AAPOS Guidelines

Clinical ophthalmology (Auckland, N.Z.), 2022-01, Vol.16, p.489-505

2022

Volltextzugriff (PDF)

Bile acids trigger cholemic nephropathy in common bile-duct-ligated mice

Hepatology (Baltimore, Md.), 2013-12, Vol.58 (6), p.2056-2069

2013

Volltextzugriff (PDF)

Intercomparison of stratospheric ozone and temperature profiles during the October 2005 Hohenpeißenberg Ozone Profiling Experiment (HOPE)

Atmospheric measurement techniques, 2009-04, Vol.2 (1), p.125-145

2009

Volltextzugriff (PDF)

93 ATGL (PNPLA2) KNOCKOUT MICE ARE PROTECTED FROM HEPATIC ER-STRESS VIA OLEIC ACID ACCUMULATION

Journal of hepatology, 2011-03, Vol.54, p.S41-S42

2011

Volltextzugriff (PDF)

913 THERAPEUTIC EFFECTS OF FXR AND TGR5 ACTIVATION IN THE MDR2 (ABCB4)−/− MOUSE MODEL OF SCLEROSING CHOLANGITIS

Journal of hepatology, 2010, Vol.52, p.S354-S354

2010

Volltextzugriff (PDF)

785 ADIPOSE TRIGLYCERIDE LIPASE (ATGL) IS A NOVEL MODULATOR OF HEPATIC ER-STRESS

Journal of hepatology, 2010, Vol.52, p.S305-S305

2010

Volltextzugriff (PDF)

Side Chain Structure Determines Unique Physiologic and Therapeutic Properties of norUrsodeoxycholic Acid in Mdr2―/― Mice

Hepatology (Baltimore, Md.), 2009-06, Vol.49 (6), p.1972-1981

2009

Volltextzugriff (PDF)

125 SIDE CHAIN MODIFIED BILE ACIDS MODULATE ENDOPLASMIC RETICULUM STRESS IN MDR2−/− MICE IN VIVO AND BILE DUCT EPITHELIAL CELLS IN VITRO

Journal of hepatology, 2008, Vol.48, p.S54-S55

2008

Volltextzugriff (PDF)

50 24-NOR-URSODEOXYCHOLIC ACID AS NOVEL THERAPEUTIC STRATEGY FOR INFLAMMATION-INDUCED LIVER FIBROSIS IN A MURINE MODEL OF SCHISTOSOMA MANSONI INFECTION

Journal of hepatology, 2008, Vol.48, p.S21-S22

2008

Volltextzugriff (PDF)

448 CURCUMIN IMPROVES LIVER INJURY AND BILIARY FIBROSIS IN MDR2 (ABCB4) KNOCKOUT MICE BY INDUCING ANTI-OXIDATIVE RESPONSE, BUT NOT VIA MODIFICATION OF BILE ACID TRANSPORT/METABOLISM

Journal of hepatology, 2008, Vol.48, p.S171-S171

2008

Volltextzugriff (PDF)

[346] EXPRESSION OF BILE ACID TRANSPORT AND DETOXIFICATION SYSTEMS AND THEIR REGULATORY NUCLEAR RECEPTORS IN HUMAN HEPATIC STELLATE CELLS

Journal of hepatology, 2007, Vol.46, p.S135-S135

2007

Volltextzugriff (PDF)

Complementary Stimulation of Hepatobiliary Transport and Detoxification Systems by Rifampicin and Ursodeoxycholic Acid in Humans

Gastroenterology (New York, N.Y. 1943), 2005, Vol.129 (2), p.476-485

2005

Volltextzugriff (PDF)

Role of farnesoid X receptor in determining hepatic ABC transporter expression and liver injury in bile duct-ligated mice

Gastroenterology (New York, N.Y. 1943), 2003-09, Vol.125 (3), p.825-838

2003

Volltextzugriff (PDF)

Adaptive changes in hepatobiliary transporter expression in primary biliary cirrhosis

Journal of hepatology, 2003-06, Vol.38 (6), p.717-727

2003

Volltextzugriff (PDF)

[48] RETENTION OF TOXIC BILE ACIDS ACTIVATE THE MTOR, P70S6K/RPS6 SIGNALING PATHWAY IN MOUSE MODELS OF CHOLESTATIC LIVER INJURY

Journal of hepatology, 2007, Vol.46, p.S23-S23

2007

Volltextzugriff (PDF)

[116] TAURINE-CONJUGATION CRITICALLY DETERMINES THE THERAPEUTIC EFFECTIVENESS OF 24-NOR-URSODEOXYCHOLIC ACID (NORUDCA) IN THE TREATMENT OF SCLEROSING CHOLANGITIS IN MDR2 (ABCB4) KNOCKOUT MICE

Journal of hepatology, 2007, Vol.46, p.S51-S51

2007

Volltextzugriff (PDF)

[5] ABSENCE OF FXR PROTECTS MICE FROM BILE-INFARCTS IN BILIARY OBSTRUCTION BY REDUCTION OF BILE ACID-INDEPENDENT BILE FLOW: IMPLICATIONS FOR TARGETING FXR IN TREATMENT OF CHOLESTASIS?

Journal of hepatology, 2007, Vol.46, p.S5-S5

2007

Volltextzugriff (PDF)

1 – 25 von 761

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(519)
Mit Volltextzugriff
(498)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Complementary stimulation of hepatobiliary transport and detoxification systems by rifampicin and ursodeoxycholic acid in humans

Curcumin improves sclerosing cholangitis in Mdr2−/− mice by inhibition of cholangiocyte inflammatory response and portal myofibroblast proliferation

50 PREGNANCY RESOLVES LIVER FIBROSIS AND IMPROVES SCLEROSING CHOLANGITIS IN MDR2 (ABCB4) −/− MICE VIA DIRECT ANTI-INFLAMMATORY EFFECTS OF SEX HORMONES

Fouling-Release Performance of Silicone Oil-Modified Siloxane-Polyurethane Coatings

Biobased, Nonisocyanate, 2K Polyurethane Coatings Produced from Polycarbamate and Dialdehyde Cross-linking

Comprehensive curation and analysis of fungal biosynthetic gene clusters of published natural products

1307 HIGH LEVELS OF URSODEOXYCHOLIC ACID ACT AS FXR ANTAGONIST AND DEPLETE LIVER CHOLESTEROL DUE TO INCREASED BILE ACID SYNTHESIS IN MORBIDLY OBESE PATIENTS

Exploration of Bio-Based Functionalized Sucrose Ester Resins for Additive Manufacturing via Stereolithography

Instrument Referral Criteria for PlusoptiX, SPOT and 2WIN Targeting 2021 AAPOS Guidelines

Bile acids trigger cholemic nephropathy in common bile-duct-ligated mice

Intercomparison of stratospheric ozone and temperature profiles during the October 2005 Hohenpeißenberg Ozone Profiling Experiment (HOPE)

93 ATGL (PNPLA2) KNOCKOUT MICE ARE PROTECTED FROM HEPATIC ER-STRESS VIA OLEIC ACID ACCUMULATION

913 THERAPEUTIC EFFECTS OF FXR AND TGR5 ACTIVATION IN THE MDR2 (ABCB4)−/− MOUSE MODEL OF SCLEROSING CHOLANGITIS

785 ADIPOSE TRIGLYCERIDE LIPASE (ATGL) IS A NOVEL MODULATOR OF HEPATIC ER-STRESS

Side Chain Structure Determines Unique Physiologic and Therapeutic Properties of norUrsodeoxycholic Acid in Mdr2―/― Mice

125 SIDE CHAIN MODIFIED BILE ACIDS MODULATE ENDOPLASMIC RETICULUM STRESS IN MDR2−/− MICE IN VIVO AND BILE DUCT EPITHELIAL CELLS IN VITRO

50 24-NOR-URSODEOXYCHOLIC ACID AS NOVEL THERAPEUTIC STRATEGY FOR INFLAMMATION-INDUCED LIVER FIBROSIS IN A MURINE MODEL OF SCHISTOSOMA MANSONI INFECTION

448 CURCUMIN IMPROVES LIVER INJURY AND BILIARY FIBROSIS IN MDR2 (ABCB4) KNOCKOUT MICE BY INDUCING ANTI-OXIDATIVE RESPONSE, BUT NOT VIA MODIFICATION OF BILE ACID TRANSPORT/METABOLISM

[346] EXPRESSION OF BILE ACID TRANSPORT AND DETOXIFICATION SYSTEMS AND THEIR REGULATORY NUCLEAR RECEPTORS IN HUMAN HEPATIC STELLATE CELLS

Complementary Stimulation of Hepatobiliary Transport and Detoxification Systems by Rifampicin and Ursodeoxycholic Acid in Humans

Role of farnesoid X receptor in determining hepatic ABC transporter expression and liver injury in bile duct-ligated mice

Adaptive changes in hepatobiliary transporter expression in primary biliary cirrhosis

[48] RETENTION OF TOXIC BILE ACIDS ACTIVATE THE MTOR, P70S6K/RPS6 SIGNALING PATHWAY IN MOUSE MODELS OF CHOLESTATIC LIVER INJURY

[116] TAURINE-CONJUGATION CRITICALLY DETERMINES THE THERAPEUTIC EFFECTIVENESS OF 24-NOR-URSODEOXYCHOLIC ACID (NORUDCA) IN THE TREATMENT OF SCLEROSING CHOLANGITIS IN MDR2 (ABCB4) KNOCKOUT MICE

[5] ABSENCE OF FXR PROTECTS MICE FROM BILE-INFARCTS IN BILIARY OBSTRUCTION BY REDUCTION OF BILE ACID-INDEPENDENT BILE FLOW: IMPLICATIONS FOR TARGETING FXR IN TREATMENT OF CHOLESTASIS?

Suchergebnisse filtern